| |
| |
|
| Insider
Information: |
Balo Andrew K |
| Relationship: |
EVP Regulatory Strateg... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
50,908 |
|
|
Indirect Shares
|
30,212 |
|
|
| Direct
Value |
$6,484,661 |
|
|
|
Indirect Value
|
$3,848,405 |
|
|
| Total
Shares |
81,120 |
|
|
| Total
Value |
$10,333,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 90.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
VP of Clinical and RegulatoryO |
• – – |
2005-04-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,500 |
|
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2019-09-03 |
4 |
AS |
$170.00 |
$6,290 |
D/D |
(37) |
69,409 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-02-10 |
4 |
OE |
$9.80 |
$7,125 |
D/D |
727 |
107,072 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2019-09-18 |
4 |
AS |
$151.46 |
$361,384 |
D/D |
(2,386) |
57,916 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-06-03 |
4 |
AS |
$375.00 |
$896,625 |
I/I |
(2,391) |
16,383 |
0 |
% |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,498 |
13,150 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-09-09 |
4 |
AS |
$0.00 |
$0 |
D/D |
(2,498) |
14,056 |
0 |
% |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2012-09-10 |
4 |
D |
$13.68 |
$37,392 |
D/D |
(2,734) |
109,733 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-08-03 |
4 |
AS |
$512.19 |
$1,422,247 |
I/I |
(2,757) |
10,652 |
0 |
% |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-07-06 |
4 |
AS |
$428.51 |
$1,279,228 |
I/I |
(2,974) |
13,409 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-01-10 |
4 |
OE |
$9.80 |
$31,360 |
D/D |
3,200 |
109,545 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-01-10 |
4 |
AS |
$62.86 |
$201,152 |
D/D |
(3,200) |
106,345 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-02-10 |
4 |
AS |
$79.30 |
$253,760 |
D/D |
(3,200) |
103,872 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-03-10 |
4 |
AS |
$77.71 |
$248,672 |
D/D |
(3,200) |
129,463 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-04-10 |
4 |
AS |
$78.19 |
$250,208 |
D/D |
(3,200) |
112,833 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-05-10 |
4 |
AS |
$71.93 |
$230,176 |
D/D |
(3,200) |
109,633 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-06-12 |
4 |
AS |
$69.06 |
$220,989 |
D/D |
(3,200) |
106,433 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-07-10 |
4 |
AS |
$71.55 |
$228,972 |
D/D |
(3,200) |
103,233 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-08-10 |
4 |
AS |
$71.18 |
$230,921 |
D/D |
(3,244) |
99,989 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-09-11 |
4 |
AS |
$72.27 |
$234,441 |
D/D |
(3,244) |
96,813 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-12-11 |
4 |
AS |
$61.23 |
$198,691 |
D/D |
(3,245) |
79,547 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Global Medical Affairs |
• – – |
2022-03-09 |
4 |
D |
$406.06 |
$1,392,774 |
D/D |
(3,430) |
15,615 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2014-09-12 |
4 |
D |
$43.36 |
$190,968 |
D/D |
(4,404) |
150,130 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-09-09 |
4 |
D |
$90.90 |
$400,317 |
D/D |
(4,404) |
138,186 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-09-14 |
4 |
D |
$95.93 |
$423,638 |
D/D |
(4,416) |
133,770 |
0 |
- |
|
200 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
